Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study Evaluating the Safety of Bevacizumab in Women With a History of Breast Cancer Suffering From Moderate to Severe Upper Extremity Lymphedema

NCT00318513 is registered in ClinicalTrials.gov with Premiere Oncology of Arizona as lead sponsor.

NCT NCT00318513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00318513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study Evaluating the Safety of Bevacizumab in Women With a History of Breast Cancer Suffering From Moderate to Severe Upper Extremity Lymphedema
Lead sponsor
Premiere Oncology of Arizona
Phase
Phase 1
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
35
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema